JP2014520523A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520523A5 JP2014520523A5 JP2014517958A JP2014517958A JP2014520523A5 JP 2014520523 A5 JP2014520523 A5 JP 2014520523A5 JP 2014517958 A JP2014517958 A JP 2014517958A JP 2014517958 A JP2014517958 A JP 2014517958A JP 2014520523 A5 JP2014520523 A5 JP 2014520523A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- tissue
- disease
- bone
- growth factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 18
- 210000000130 stem cell Anatomy 0.000 claims 17
- 210000001519 tissue Anatomy 0.000 claims 12
- 210000000988 bone and bone Anatomy 0.000 claims 10
- 201000010099 disease Diseases 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 10
- 208000014674 injury Diseases 0.000 claims 9
- 230000008733 trauma Effects 0.000 claims 9
- 238000000034 method Methods 0.000 claims 8
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 claims 7
- 102100037852 Insulin-like growth factor I Human genes 0.000 claims 7
- 210000005087 mononuclear cell Anatomy 0.000 claims 7
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 6
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 6
- 206010031252 Osteomyelitis Diseases 0.000 claims 5
- 238000012258 culturing Methods 0.000 claims 5
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 4
- 101710082513 C-X-C chemokine receptor type 4 Proteins 0.000 claims 4
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims 4
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims 4
- 108010074328 Interferon-gamma Proteins 0.000 claims 4
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims 4
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 4
- 230000000747 cardiac effect Effects 0.000 claims 4
- 210000005003 heart tissue Anatomy 0.000 claims 4
- 230000002207 retinal effect Effects 0.000 claims 4
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims 3
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims 3
- 108010031794 IGF Type 1 Receptor Proteins 0.000 claims 3
- 102000038455 IGF Type 1 Receptor Human genes 0.000 claims 3
- 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 claims 3
- 208000000175 Nail-Patella Syndrome Diseases 0.000 claims 3
- 102100023472 P-selectin Human genes 0.000 claims 3
- 206010064930 age-related macular degeneration Diseases 0.000 claims 3
- 230000000735 allogeneic effect Effects 0.000 claims 3
- 229940126864 fibroblast growth factor Drugs 0.000 claims 3
- 208000002780 macular degeneration Diseases 0.000 claims 3
- 201000008482 osteoarthritis Diseases 0.000 claims 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims 2
- 208000010392 Bone Fractures Diseases 0.000 claims 2
- 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 claims 2
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 claims 2
- 102100036166 C-X-C chemokine receptor type 1 Human genes 0.000 claims 2
- 101710082501 C-X-C chemokine receptor type 1 Proteins 0.000 claims 2
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 claims 2
- 101710082498 C-X-C chemokine receptor type 2 Proteins 0.000 claims 2
- 108091008927 CC chemokine receptors Proteins 0.000 claims 2
- 102000005674 CCR Receptors Human genes 0.000 claims 2
- 102100024210 CD166 antigen Human genes 0.000 claims 2
- 108010008951 Chemokine CXCL12 Proteins 0.000 claims 2
- 102100023471 E-selectin Human genes 0.000 claims 2
- 108091008794 FGF receptors Proteins 0.000 claims 2
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 2
- 102100022623 Hepatocyte growth factor receptor Human genes 0.000 claims 2
- 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 claims 2
- 101000622137 Homo sapiens P-selectin Proteins 0.000 claims 2
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 claims 2
- 206010020707 Hyperparathyroidism primary Diseases 0.000 claims 2
- 102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 claims 2
- 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 claims 2
- 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 claims 2
- 102100037850 Interferon gamma Human genes 0.000 claims 2
- 102000008070 Interferon-gamma Human genes 0.000 claims 2
- 102000004125 Interleukin-1alpha Human genes 0.000 claims 2
- 108010082786 Interleukin-1alpha Proteins 0.000 claims 2
- 102100039078 Interleukin-4 receptor subunit alpha Human genes 0.000 claims 2
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 claims 2
- 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 claims 2
- 102000004890 Interleukin-8 Human genes 0.000 claims 2
- 108090001007 Interleukin-8 Proteins 0.000 claims 2
- 102100033467 L-selectin Human genes 0.000 claims 2
- 208000029725 Metabolic bone disease Diseases 0.000 claims 2
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 claims 2
- 201000000981 Primary Hyperparathyroidism Diseases 0.000 claims 2
- 108010089836 Proto-Oncogene Proteins c-met Proteins 0.000 claims 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 2
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims 2
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims 2
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims 2
- -1 collagen-2 Proteins 0.000 claims 2
- 201000010934 exostosis Diseases 0.000 claims 2
- 230000003176 fibrotic effect Effects 0.000 claims 2
- 229960003130 interferon gamma Drugs 0.000 claims 2
- 229940096397 interleukin-8 Drugs 0.000 claims 2
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 108010017843 platelet-derived growth factor A Proteins 0.000 claims 2
- 102000005962 receptors Human genes 0.000 claims 2
- 108020003175 receptors Proteins 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 2
- 102100022464 5'-nucleotidase Human genes 0.000 claims 1
- 108010075348 Activated-Leukocyte Cell Adhesion Molecule Proteins 0.000 claims 1
- 101710145634 Antigen 1 Proteins 0.000 claims 1
- 206010005949 Bone cancer Diseases 0.000 claims 1
- 208000020084 Bone disease Diseases 0.000 claims 1
- 206010061728 Bone lesion Diseases 0.000 claims 1
- 208000018084 Bone neoplasm Diseases 0.000 claims 1
- 102100032366 C-C motif chemokine 7 Human genes 0.000 claims 1
- 102100032912 CD44 antigen Human genes 0.000 claims 1
- 102100036364 Cadherin-2 Human genes 0.000 claims 1
- 102100037182 Cation-independent mannose-6-phosphate receptor Human genes 0.000 claims 1
- 102000019034 Chemokines Human genes 0.000 claims 1
- 108010012236 Chemokines Proteins 0.000 claims 1
- 208000013725 Chronic Kidney Disease-Mineral and Bone disease Diseases 0.000 claims 1
- 208000002330 Congenital Heart Defects Diseases 0.000 claims 1
- 108010024212 E-Selectin Proteins 0.000 claims 1
- 208000005189 Embolism Diseases 0.000 claims 1
- 102100037241 Endoglin Human genes 0.000 claims 1
- 208000006367 Essential Osteolysis Diseases 0.000 claims 1
- 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 claims 1
- 206010017076 Fracture Diseases 0.000 claims 1
- 208000019683 Gorham-Stout disease Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims 1
- 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 claims 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 1
- 101000622123 Homo sapiens E-selectin Proteins 0.000 claims 1
- 101000881679 Homo sapiens Endoglin Proteins 0.000 claims 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 1
- 101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 claims 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims 1
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 claims 1
- 101000599862 Homo sapiens Intercellular adhesion molecule 3 Proteins 0.000 claims 1
- 101001018097 Homo sapiens L-selectin Proteins 0.000 claims 1
- 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 claims 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims 1
- 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 claims 1
- 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 claims 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims 1
- 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 claims 1
- 101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 claims 1
- 101000801232 Homo sapiens Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 claims 1
- 206010049933 Hypophosphatasia Diseases 0.000 claims 1
- 206010021143 Hypoxia Diseases 0.000 claims 1
- 108050009527 Hypoxia-inducible factor-1 alpha Proteins 0.000 claims 1
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims 1
- 102100025304 Integrin beta-1 Human genes 0.000 claims 1
- 102100025390 Integrin beta-2 Human genes 0.000 claims 1
- 102000012334 Integrin beta4 Human genes 0.000 claims 1
- 108010022238 Integrin beta4 Proteins 0.000 claims 1
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 claims 1
- 101710148794 Intercellular adhesion molecule 2 Proteins 0.000 claims 1
- 108010038452 Interleukin-3 Receptors Proteins 0.000 claims 1
- 102000010790 Interleukin-3 Receptors Human genes 0.000 claims 1
- 108010038486 Interleukin-4 Receptors Proteins 0.000 claims 1
- 108010038501 Interleukin-6 Receptors Proteins 0.000 claims 1
- 108010038498 Interleukin-7 Receptors Proteins 0.000 claims 1
- 108010092694 L-Selectin Proteins 0.000 claims 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 claims 1
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 claims 1
- 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 claims 1
- 208000030136 Marchiafava-Bignami Disease Diseases 0.000 claims 1
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims 1
- 101100096242 Mus musculus Sox9 gene Proteins 0.000 claims 1
- 208000009525 Myocarditis Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 102100028762 Neuropilin-1 Human genes 0.000 claims 1
- 208000002804 Osteochondritis Diseases 0.000 claims 1
- 201000009859 Osteochondrosis Diseases 0.000 claims 1
- 206010031243 Osteogenesis imperfecta Diseases 0.000 claims 1
- 206010031264 Osteonecrosis Diseases 0.000 claims 1
- 206010049088 Osteopenia Diseases 0.000 claims 1
- 208000008558 Osteophyte Diseases 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 108010035766 P-Selectin Proteins 0.000 claims 1
- 102100040681 Platelet-derived growth factor C Human genes 0.000 claims 1
- 102100040682 Platelet-derived growth factor D Human genes 0.000 claims 1
- 101710170209 Platelet-derived growth factor D Proteins 0.000 claims 1
- 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 claims 1
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 claims 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 claims 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 claims 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 1
- 208000000924 Right ventricular hypertrophy Diseases 0.000 claims 1
- 208000005688 Salter-Harris Fractures Diseases 0.000 claims 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims 1
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 claims 1
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 claims 1
- 102100040247 Tumor necrosis factor Human genes 0.000 claims 1
- 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 claims 1
- 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 claims 1
- 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 claims 1
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 claims 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 1
- 101150045355 akt1 gene Proteins 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 230000006793 arrhythmia Effects 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 230000000903 blocking effect Effects 0.000 claims 1
- 208000016738 bone Paget disease Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000021164 cell adhesion Effects 0.000 claims 1
- 208000028831 congenital heart disease Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 208000018578 heart valve disease Diseases 0.000 claims 1
- 201000010930 hyperostosis Diseases 0.000 claims 1
- 230000001146 hypoxic effect Effects 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 239000006166 lysate Substances 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000003716 mesoderm Anatomy 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- 230000005012 migration Effects 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 230000008520 organization Effects 0.000 claims 1
- 208000002865 osteopetrosis Diseases 0.000 claims 1
- 208000028169 periodontal disease Diseases 0.000 claims 1
- 108010017992 platelet-derived growth factor C Proteins 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 201000006409 renal osteodystrophy Diseases 0.000 claims 1
- 210000003625 skull Anatomy 0.000 claims 1
- 229940099456 transforming growth factor beta 1 Drugs 0.000 claims 1
- 210000005167 vascular cell Anatomy 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1111500.3 | 2011-07-06 | ||
| GBGB1111503.7A GB201111503D0 (en) | 2011-07-06 | 2011-07-06 | Heart failure (HF) MSC subtype |
| GBGB1111500.3A GB201111500D0 (en) | 2011-07-06 | 2011-07-06 | Wet age-related macular degeneration MSC subtype |
| GB1111505.2 | 2011-07-06 | ||
| GB1111503.7 | 2011-07-06 | ||
| GB1111509.4 | 2011-07-06 | ||
| GBGB1111509.4A GB201111509D0 (en) | 2011-07-06 | 2011-07-06 | Orthopedic MSC subtype |
| GBGB1111505.2A GB201111505D0 (en) | 2011-07-06 | 2011-07-06 | MI MSC subtype |
| PCT/GB2012/051600 WO2013005053A2 (en) | 2011-07-06 | 2012-07-06 | Progenitor cells of mesodermal lineage |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017144116A Division JP2017225451A (ja) | 2011-07-06 | 2017-07-26 | 中胚葉系列の前駆細胞 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520523A JP2014520523A (ja) | 2014-08-25 |
| JP2014520523A5 true JP2014520523A5 (enExample) | 2015-07-16 |
| JP6607675B2 JP6607675B2 (ja) | 2019-11-20 |
Family
ID=46513785
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517958A Active JP6607675B2 (ja) | 2011-07-06 | 2012-07-06 | 中胚葉系列の前駆細胞 |
| JP2017144116A Pending JP2017225451A (ja) | 2011-07-06 | 2017-07-26 | 中胚葉系列の前駆細胞 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017144116A Pending JP2017225451A (ja) | 2011-07-06 | 2017-07-26 | 中胚葉系列の前駆細胞 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10472609B2 (enExample) |
| EP (1) | EP2729562B1 (enExample) |
| JP (2) | JP6607675B2 (enExample) |
| CN (2) | CN104508124B (enExample) |
| AU (2) | AU2012279995C1 (enExample) |
| CA (1) | CA2840307C (enExample) |
| CY (1) | CY1120646T1 (enExample) |
| DK (1) | DK2729562T3 (enExample) |
| EA (1) | EA029577B1 (enExample) |
| ES (1) | ES2675693T3 (enExample) |
| HR (1) | HRP20181152T1 (enExample) |
| HU (1) | HUE039236T2 (enExample) |
| IL (2) | IL230071B (enExample) |
| LT (1) | LT2729562T (enExample) |
| MY (1) | MY185016A (enExample) |
| PL (1) | PL2729562T3 (enExample) |
| PT (1) | PT2729562T (enExample) |
| SG (1) | SG10201605518XA (enExample) |
| WO (1) | WO2013005053A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120087868A1 (en) | 2010-10-08 | 2012-04-12 | Gabriele Todd | Nanoparticle-loaded cells |
| PL2782555T3 (pl) * | 2011-11-23 | 2019-09-30 | Cell Therapy Limited | Żel z lizatem płytek krwi |
| JP6615753B2 (ja) * | 2013-10-04 | 2019-12-04 | レジニアス リミテッド | 細胞療法のためのバイオマーカー |
| GB201408712D0 (en) * | 2014-05-16 | 2014-07-02 | Univ Leuven Kath | Mesodermal progenitor cells |
| GB201410504D0 (en) | 2014-06-12 | 2014-07-30 | Cell Therapy Ltd | Immuno-modulaltory progenitor (IMP) cell |
| CN107076745A (zh) * | 2014-08-29 | 2017-08-18 | 贝克顿·迪金森公司 | 在受试者中获得结核病评价的方法和组合物 |
| JP2018512061A (ja) * | 2015-02-20 | 2018-05-10 | ナショナル ヤン−ミン ユニバーシティ | 骨関節炎処置のための間葉幹細胞の使用 |
| EP3091084A1 (en) * | 2015-05-08 | 2016-11-09 | Université Catholique De Louvain | Methods for assessing the purity of a mesenchymal stem cells preparation |
| GB201513996D0 (en) | 2015-08-07 | 2015-09-23 | Cell Therapy Ltd | Immuno-oncology mesodermal progenitor (IOMP) cell |
| JP6830893B2 (ja) | 2015-09-11 | 2021-02-17 | アステラス製薬株式会社 | 腎前駆細胞を製造する方法 |
| GB201518263D0 (en) | 2015-10-15 | 2015-12-02 | Oxford Bioelectronics Ltd | Method |
| CN105483206B (zh) * | 2016-01-06 | 2019-09-13 | 北京汉氏联合生物技术股份有限公司 | 一种用vcam-1检测msc促内皮细胞增殖能力的方法 |
| US11066648B2 (en) * | 2016-08-29 | 2021-07-20 | Hackensack University Medical Center | Compositions and methods for reprogramming adult cells through the stemness of a platelet rich fraction of blood containing platelet-like cells in humans |
| CA3033750A1 (en) * | 2016-08-29 | 2018-03-08 | Hackensack University Medical Center | Compositions and methods for programming adult cells with platelet rich fraction of blood containing platelet-like cells |
| CN112004923A (zh) | 2017-11-22 | 2020-11-27 | 迈索布拉斯特国际有限公司 | 细胞组合物及治疗方法 |
| JP7009977B2 (ja) * | 2017-12-25 | 2022-01-26 | 国立大学法人東海国立大学機構 | 被検体の血中ｖｅｇｆ－ａに関する測定値を用いた心疾患の重症度及び予後予測を行うための方法、装置及びコンピュータプログラム |
| CN108715833B (zh) * | 2018-06-01 | 2021-09-14 | 天晴干细胞股份有限公司 | 一种负载血小板裂解液的微球制备方法 |
| CN108715834B (zh) * | 2018-06-01 | 2021-09-14 | 天晴干细胞股份有限公司 | 一种富含cd41+、cd81+微囊的血小板裂解液制备方法 |
| US12310989B2 (en) * | 2018-11-14 | 2025-05-27 | Onderzoeks- En Ontwikkelingsfonds Rode Kruis-Vlaanderen | Methods for preparing platelet releasate |
| CN109329270A (zh) * | 2018-11-19 | 2019-02-15 | 成都清科生物科技有限公司 | 一种静脉回输用间充质干细胞保存液及其制备方法 |
| GB201900554D0 (en) | 2019-01-15 | 2019-03-06 | Cell Therapy Ltd | Mesodermal killer (mk) cell |
| US20230047325A1 (en) * | 2019-01-15 | 2023-02-16 | Cell Therapy Limited | Mesodermal killer (mk) cell |
| WO2020157660A1 (en) * | 2019-01-28 | 2020-08-06 | Mesoblast International Sárl | Method for treating or preventing gastrointestinal bleeding |
| EP3968992A4 (en) * | 2019-05-15 | 2023-06-21 | Stemcyte, Inc. | PACKAGING AND SHIPPING HIGH CONCENTRATION CELLS |
| CN110237094B (zh) * | 2019-07-30 | 2023-10-03 | 天晴干细胞股份有限公司 | 一种底层血小板因子贴及sPL血小板因子凝胶贴膜的制备方法 |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8801537D0 (sv) | 1988-04-26 | 1988-04-26 | Ellco Food Ab | Cellodlingsmedium samt forfarande for dess framstellning |
| RU2138162C1 (ru) | 1997-04-17 | 1999-09-27 | Суханов Владимир Александрович | Способ криоконсервации богатой тромбоцитами плазмы |
| EP1028737B1 (en) | 1997-07-03 | 2007-04-04 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells from peripheral blood |
| WO1999011287A1 (en) | 1997-09-04 | 1999-03-11 | Osiris Therapeutics, Inc. | Ligands that modulate differentiation of mesenchymal stem cells |
| EP1082410B1 (en) | 1998-05-29 | 2007-08-01 | Osiris Therapeutics, Inc. | Human cd45+ and/or fibroblast + mesenchymal stem cells |
| AU2003901668A0 (en) | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| DK1226233T3 (da) | 1999-08-05 | 2011-10-03 | Abt Holding Co | Multipotente voksne stamceller og fremgangsmåder til isolering heraf |
| AUPR703601A0 (en) | 2001-08-15 | 2001-09-06 | Peter Maccallum Cancer Institute, The | Identification and isolation of somatic stem cells and uses thereof |
| JP2003055237A (ja) * | 2001-08-15 | 2003-02-26 | Japan Science & Technology Corp | 骨再生促進剤 |
| DE60314602T2 (de) | 2002-02-19 | 2008-02-28 | Medipost, Co., Ltd. | Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe |
| KR100534215B1 (ko) | 2003-11-11 | 2005-12-08 | (주)히스토스템 | 냉동 보관된 제대혈로부터 중간엽 줄기세포의 분리 및 배양 방법 |
| DE102005011568A1 (de) | 2004-04-13 | 2005-11-17 | Man Roland Druckmaschinen Ag | Produktionsverfahren für eine Prägeeinrichtung in einer Bogendruckmaschine |
| US20090047257A1 (en) | 2004-07-20 | 2009-02-19 | Case Western Reserve University | Novel cell populations and uses thereof |
| AU2005287855B2 (en) | 2004-09-24 | 2011-06-16 | Mesoblast, Inc. | Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC) |
| US20080260694A1 (en) | 2004-09-24 | 2008-10-23 | Angioblast Systems, Inc. | Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof |
| KR101617319B1 (ko) | 2005-04-12 | 2016-05-02 | 메소블라스트, 아이엔씨. | 조직 비특이적인 알카리 포스파타제에 의한 다분화성 성체 세포의 분리 |
| KR100679642B1 (ko) * | 2005-11-16 | 2007-02-06 | 주식회사 알앤엘바이오 | 인간 지방조직 유래 다분화능 줄기세포 및 이를 함유하는세포치료제 |
| EP1795588A1 (en) | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| ES2415855T3 (es) | 2006-01-13 | 2013-07-29 | Osiris Therapeutics, Inc. | Células troncales mesenquimatosas que expresan el receptor de TNF |
| EP1845154A1 (en) | 2006-04-12 | 2007-10-17 | RNL Bio Co., Ltd. | Multipotent stem cells derived from placenta tissue and cellular therapeutic agents comprising the same |
| US20100111910A1 (en) | 2006-07-12 | 2010-05-06 | Angioblast Systems, Inc. | Treatment of excessive neovascularization |
| US20090253151A1 (en) | 2006-09-01 | 2009-10-08 | Stempeutics Research Private Limited | Self-Renewing Master Adult Pluripotent Stem Cells |
| WO2008097828A2 (en) | 2007-02-02 | 2008-08-14 | St. Jude Children's Research Hospital | Method for isolating mesenchymal stromal cells |
| WO2008129563A2 (en) | 2007-04-23 | 2008-10-30 | Stempeutics Research Private Limited, | Human mesenchymal stem cells and preparation thereof |
| US20090053182A1 (en) | 2007-05-25 | 2009-02-26 | Medistem Laboratories, Inc. | Endometrial stem cells and methods of making and using same |
| US9095562B2 (en) * | 2007-07-05 | 2015-08-04 | Regenerative Sciences, Inc. | Methods and compositions for optimized expansion and implantation of mesenchymal stem cells |
| EP2014294A1 (en) | 2007-07-13 | 2009-01-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of CD200 as a mesenchymal stem cells marker |
| WO2009044943A1 (en) | 2007-10-01 | 2009-04-09 | Seoul National University Industry Foundation | Various human dental stem cells having a mineralization ability and the method for culturing them |
| WO2009061024A1 (en) | 2007-11-09 | 2009-05-14 | Rnl Bio Co., Ltd | Method for isolating and culturing adult stem cells derived from human amniotic epithelium |
| CA2692765C (en) * | 2007-11-30 | 2015-09-22 | Rnl Bio Co., Ltd | Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose |
| EP2297305A4 (en) | 2008-05-15 | 2013-03-13 | Univ Miami | ISOLATION OF STEM CELL PROCESSORS AND EXPANSION UNDER NON-TERMS OF CONDITION |
| WO2010005527A1 (en) | 2008-06-30 | 2010-01-14 | Angioblast Systems, Inc. | Treatment of eye diseases and excessive neovascularization using a combined therapy |
| EP2321408A4 (en) | 2008-08-04 | 2013-04-17 | Allocure Inc | MESENCHYMAL STROMAZELL POPULATIONS AND PROCESS FOR THEIR INSULATION AND USE |
| US9090678B2 (en) | 2008-08-18 | 2015-07-28 | Mesoblast, Inc. | Monoclonal antibody STRO-4 |
| JP5793724B2 (ja) * | 2008-08-22 | 2015-10-14 | 公益財団法人ヒューマンサイエンス振興財団 | 脳梗塞治療材 |
| EP2334785B2 (en) | 2008-09-16 | 2019-08-14 | Mayo Foundation For Medical Education And Research | Compositions containing platelet contents |
| EP2186883A1 (en) | 2008-11-04 | 2010-05-19 | Fresenius Medical Care | An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney |
| KR102011609B1 (ko) | 2008-11-20 | 2019-08-16 | 메소블라스트, 아이엔씨. | 췌장 기능장애를 치료 또는 예방하는 방법 |
| US20120020937A1 (en) | 2009-04-28 | 2012-01-26 | Anterogen Co., Ltd. | Autologous and allogenic adipose-derived stromal stem cell composition for treating fistulas |
| EP2488187A4 (en) | 2009-10-13 | 2014-03-26 | Allocure Inc | ASSAY FOR PREDICTING THE THERAPEUTIC EFFECT OF MECHANICAL CYCLES AND METHOD OF USE THEREOF |
| ES2358146B1 (es) | 2009-10-22 | 2012-03-23 | Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud En Sevilla | Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis. |
| US20110123498A1 (en) | 2009-10-30 | 2011-05-26 | Christof Westenfelder | Mesenchymal stromal cell populations and methods of using same |
| CN102048756B (zh) | 2009-11-04 | 2014-02-19 | 中国医学科学院基础医学研究所 | 人脂肪来源的间充质干细胞在肾脏、眼底疾病中的用途 |
| WO2011068792A2 (en) | 2009-12-01 | 2011-06-09 | The Regents Of The University Of California | Compositions and methods for making and using bone marrow mesenchymal stem cells and erythroid progenitor cells |
| EP2506867B1 (en) * | 2009-12-02 | 2014-10-08 | Cardio3 Biosciences S.A. | Pharmaceutical compositions for the stimulation of stem cells. |
| KR101871472B1 (ko) | 2010-07-02 | 2018-06-27 | 메소블라스트, 아이엔씨. | 이식편대숙주 질환의 치료 방법 |
| JP6061345B2 (ja) | 2010-08-27 | 2017-01-18 | ユニヴァーシティ・オヴ・マイアミ | 心臓修復のための骨髄由来ｃｄ２７１前駆細胞 |
| US20120087868A1 (en) | 2010-10-08 | 2012-04-12 | Gabriele Todd | Nanoparticle-loaded cells |
| ES2384790B1 (es) | 2010-12-10 | 2013-05-20 | Instituto De Salud Carlos Iii | Células madre mesenquimales aisladas a partir de sangre periférica. |
| US20120288480A1 (en) | 2011-02-22 | 2012-11-15 | Taipei Medical University | Cell population comprising orbital fat-derived stem cells (ofscs) and their isolation and applications |
| CN102078644A (zh) * | 2011-03-08 | 2011-06-01 | 吉林大学 | 一种简便高效的自体富血小板血浆提取装置及提取方法 |
| SG194930A1 (en) | 2011-05-19 | 2013-12-30 | Mesoblast Inc | Methods for treating obesity and/or metabolic syndrome |
| CN103826646A (zh) | 2011-06-03 | 2014-05-28 | 麦瑟布莱斯特公司 | 治疗中风的影响的方法 |
| CN109276706A (zh) | 2011-06-03 | 2019-01-29 | 麦瑟布莱斯特公司 | 治疗或预防神经性疾病的方法 |
| WO2013003899A1 (en) | 2011-07-04 | 2013-01-10 | Mesoblast, Inc | Methods of treating or preventing rheumatic disease |
| CN108635377B (zh) | 2011-09-09 | 2022-06-24 | 麦瑟布莱斯特公司 | 增加成骨细胞功能的方法 |
| JP6348848B2 (ja) | 2012-02-13 | 2018-06-27 | ガミダ セル リミテッド | 間葉系幹細胞の増殖 |
| US20150064141A1 (en) | 2012-04-05 | 2015-03-05 | The Regents Of The University Of California | Regenerative sera cells and mesenchymal stem cells |
| US20130273011A1 (en) | 2012-04-17 | 2013-10-17 | Medistem, Inc. | Stem cells and stem cell generated nanoparticles for treatment of inflammatory conditions and acute radiation syndrome |
-
2012
- 2012-07-06 EP EP12735321.7A patent/EP2729562B1/en active Active
- 2012-07-06 US US14/130,840 patent/US10472609B2/en active Active
- 2012-07-06 HR HRP20181152TT patent/HRP20181152T1/hr unknown
- 2012-07-06 MY MYPI2014000615A patent/MY185016A/en unknown
- 2012-07-06 JP JP2014517958A patent/JP6607675B2/ja active Active
- 2012-07-06 AU AU2012279995A patent/AU2012279995C1/en active Active
- 2012-07-06 DK DK12735321.7T patent/DK2729562T3/en active
- 2012-07-06 PT PT127353217T patent/PT2729562T/pt unknown
- 2012-07-06 CN CN201280033446.3A patent/CN104508124B/zh active Active
- 2012-07-06 ES ES12735321.7T patent/ES2675693T3/es active Active
- 2012-07-06 LT LTEP12735321.7T patent/LT2729562T/lt unknown
- 2012-07-06 HU HUE12735321A patent/HUE039236T2/hu unknown
- 2012-07-06 SG SG10201605518XA patent/SG10201605518XA/en unknown
- 2012-07-06 WO PCT/GB2012/051600 patent/WO2013005053A2/en not_active Ceased
- 2012-07-06 CN CN201710962767.6A patent/CN107746830A/zh active Pending
- 2012-07-06 CA CA2840307A patent/CA2840307C/en active Active
- 2012-07-06 PL PL12735321T patent/PL2729562T3/pl unknown
- 2012-07-06 EA EA201391773A patent/EA029577B1/ru not_active IP Right Cessation
-
2013
- 2013-12-22 IL IL230071A patent/IL230071B/en active IP Right Review Request
-
2017
- 2017-06-30 AU AU2017204559A patent/AU2017204559A1/en not_active Abandoned
- 2017-07-26 JP JP2017144116A patent/JP2017225451A/ja active Pending
-
2018
- 2018-07-16 CY CY181100736T patent/CY1120646T1/el unknown
-
2019
- 2019-01-24 IL IL264455A patent/IL264455A/en unknown
- 2019-10-08 US US16/596,301 patent/US10829739B2/en active Active
-
2020
- 2020-10-07 US US17/065,335 patent/US11873513B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014520523A5 (enExample) | ||
| US11873513B2 (en) | Progenitor cells of mesodermal lineage | |
| Malliaras et al. | Cardiac cell therapy: where we've been, where we are, and where we should be headed | |
| Li et al. | In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury | |
| Fuchs et al. | Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study | |
| Nygren et al. | Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation | |
| JP6185657B2 (ja) | 免疫調節前駆（ｉｍｐ）細胞 | |
| US20100172885A1 (en) | Multipotent Adult Stem Cells And Uses of Multipotent Adult Stem Cells To Treat Inflammation | |
| Marquez-Curtis et al. | CXCR4 transfection of cord blood mesenchymal stromal cells with the use of cationic liposome enhances their migration toward stromal cell–derived factor-1 | |
| JP2015507921A5 (enExample) | ||
| Huang et al. | Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro | |
| He et al. | Injection of Sca-1+/CD45+/CD31+ mouse bone mesenchymal stromal-like cells improves cardiac function in a mouse myocardial infarct model | |
| Strauer et al. | The therapeutic potential of stem cells in heart disease | |
| Zisa et al. | Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair | |
| Shi et al. | Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease | |
| Locatelli et al. | Efficient plasmid-mediated gene transfection of ovine bone marrow mesenchymal stromal cells | |
| Sato et al. | Safety of intravenous autologous bone marrow-derived mesenchymal cell transplantation in 5 patients with reduced left ventricular ejection fraction | |
| TW202012617A (zh) | 無血清培養液以及使用此無血清培養液分離和放大培養幹細胞方法 | |
| Viswanathan et al. | Mesenchymal stromal cells: latest advances | |
| Bigildeev | Transplantation of MSCs for a Longstanding Engraftment and Maintenance of Bone Marrow Stroma | |
| Manferdini et al. | Specific effects of osteoarthritic milieu and hypoxic conditions on adipose mesenchymal stromal cell migration and cytokine receptors expression | |
| Lange et al. | Platelet lysate for rapid expansion of human mesenchymal stromal cells | |
| Gathier et al. | Adipose-derived stem cells | |
| Caruso et al. | Multipotent Mesenchymal Stromal Cell-Based Therapies: Regeneration Versus Repair | |
| Jankowski et al. | ISOLATION AND FUNCTIONAL ASSESSMENT OF MYOGENIC PRECURSORS IDENTIFIED VIA SURFACE PROTEIN EXPRESSION |